The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...
In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...
When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.
Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart. Here, we look at the ...
Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...
TipRanks on MSN3d
NeoGenomics price target lowered to $17 from $18 at BTIGBTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...
When U.S. investors return from the long weekend they will be faced with a stock market looking well-positioned to break out to fresh record highs. But any such move into virgin territory may precede ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback